United States · FDA National Drug Code directory
Gemfibrozil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-745_3ef18652-9145-bc21-e063-6394a90a74fb
- Product NDC
- 43063-745
- Form
- TABLET
- Composition / generic term
- Gemfibrozil
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161013
- Source listing expiry
- 20261231
Source-listed ingredients
- GEMFIBROZIL — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-745-60) · 43063-745-60
- 180 TABLET in 1 BOTTLE, PLASTIC (43063-745-93) · 43063-745-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →